What does Pharmalex do?
PHARMALEX is a global consulting firm specializing in regulatory affairs, quality assurance, and clinical development for the pharmaceutical and biotechnology industries. The company provides expert guidance and support to help clients navigate complex regulatory environments and bring their products to market efficiently. With a strong focus on compliance and innovation, PHARMALEX aims to enhance the success of its clients' projects across various therapeutic areas.
- Sectors
- Accountants
- Signals
-
ProfitableProfitable € 88K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 1.92MStrong equity provides a buffer against setbacks.
Low riskLow risk 84.3%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 6.37A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 66KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 90KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 14.3%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
1.16M
|
€
1.22M
|
€
1.23M
|
€
596K
|
|
|
€
90K
|
€
254K
|
€
478K
|
€
237K
|
|
|
€
65K
|
€
174K
|
€
369K
|
€
177K
|
|
|
€
1.92M
|
€
1.90M
|
€
1.97M
|
€
1.90M
|
|
|
84.33%
|
75.17%
|
76.81%
|
80.11%
|
|
|
€
356K
|
€
627K
|
€
594K
|
€
472K
|
|
|
€
432K
|
€
322K
|
€
407K
|
€
775K
|
|
|
11.20
|
12.20
|
14.20
|
|
Publications 21
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Divers - Objet - Demissions, Nominations 03/08/2026
- Demissions, Nominations 28/02/2023
- Modification Forme Juridique - Objet - Demissions, Nominations - Assemblee Generale - Annee Comptable 28/06/2022
- Capital, Actions 22/01/2018
- Me. - Comptes Annuels 31.12.2015, App 30.06.2016, Dpt 05.08.2016 16409-0108-014 11/08/2016
Frequently asked questions
Answers to the most common questions about Pharmalex, based on official government data and the filed annual accounts.
What is the VAT number of Pharmalex?
The VAT number of Pharmalex is BE0471.925.883.
How many employees work at Pharmalex?
In 2025, Pharmalex employed 11.20 full-time equivalents (FTE).
When was Pharmalex established?
Pharmalex was founded in 19-05-2000.
What is the official address of Pharmalex?
The official address of Pharmalex is Rue De Mulhouse 33/B Liège 4020.
What is the legal form of Pharmalex?
The juridical form of Pharmalex is Private limited company (BV/SRL).
What is the annual revenue of Pharmalex?
The 2025 accounts of Pharmalex do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Pharmalex do?
PHARMALEX is a global consulting firm specializing in regulatory affairs, quality assurance, and clinical development for the pharmaceutical and biotechnology industries. The company provides expert guidance and support to help clients navigate complex regulatory environments and bring their products to market efficiently. With a strong focus on compliance and innovation, PHARMALEX aims to enhance the success of its clients' projects across various therapeutic areas.
Is Pharmalex a reliable company?
Pharmalex is a registered Rechtspersoon with company number 0471.925.883 and can be verified through the official CBE database.
What is the credit limit of Pharmalex?
The estimated credit limit of Pharmalex is €181,133.
Is Pharmalex still active?
Pharmalex currently has the status "Normal situation" and is active.